Two months into Kennedy’s leadership of HHS, attorneys say they are still waiting to see where the new secretary might steer the department and the agencies it oversees, and what his decisions could mean for litigation over things like pharmaceuticals and food products.
Two months into Kennedy’s leadership of HHS, attorneys say they are still waiting to see where the new secretary might steer the department and the agencies it oversees, and what his decisions could mean for litigation over things like pharmaceuticals and food products.
